COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,874 Articles (22,568 medRxiv, 8,306 bioRxiv)

Most recent first Previous |  Page 2892: Articles 28911-28920  | Next

Diagnosis and Prediction Model for COVID19 Patients Response to Treatment based on Convolutional Neural Networks and Whale Optimization Algorithm Using CT Images
ELGhamrawy, S. M., Hassanien, A. E.
10.1101/2020.04.16.20063990 — Posted: 2020-04-21 Discussion: Onsite | Offsite
Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools
Nguyen, T. T., Lai, H. T. T., Nguyen, L. H., Nguyen-Manh, D., Kranjc Pietrucci, A. T.
10.1101/2020.04.21.053009 — Posted: 2020-04-21
Synonymous mutations and the molecular evolution of SARS-Cov-2 origins
Nielsen, R., Wang, H., Pipes, L.
10.1101/2020.04.20.052019 — Posted: 2020-04-21 Discussion: Onsite
Bioinformatics Study on Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) For Better Understanding the Vaccine Development
Gulzar, S., Hussain, S.
10.1101/2020.04.21.053199 — Posted: 2020-04-21
Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2
Kang, Y.-L., Chou, Y.-Y., Rothlauf, P. W., Liu, Z., Piccinotti, S., Soh, T. K., Cureton, D., Case, J. B., Chen, R. E., Diamond, M. S., Whelan, S. P. J., Kirchhausen, T.
10.1101/2020.04.21.053058 — Posted: 2020-04-21
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs
Malone, B., Simovski, B., Moline, C., Cheng, J., Gheorghe, M., Fontenelle, H., Vardaxis, I., Tennoe, S., Malmberg, J.-A., Stratford, R., Clancy, T.
10.1101/2020.04.21.052084 — Posted: 2020-04-21
SARS-CoV-2 Encodes a PPxY Late Domain Motif that is Known to Enhance 1 Budding and Spread in Enveloped RNA Viruses
maaroufi, H.
10.1101/2020.04.20.052217 — Posted: 2020-04-21
No evidence that androgen regulation of pulmonary TMPRSS2 explains sex-discordant COVID-19 outcomes
Baratchian, M., McManus, J., Berk, M., Nakamura, F., Erzurum, S., Mukhopadhyay, S., Drazba, J., Peterson, J., Gaston, B., Sharifi, N.
10.1101/2020.04.21.051201 — Posted: 2020-04-21 Discussion: Onsite
A Scalable, Easy-to-Deploy, Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material
Rauch, J. N., Valois, E., Solley, S. C., Braig, F., Lach, R. S., Baxter, N. J., Kosik, K. S., Arias, C., Acosta-Alvear, D., Wilson, M. Z.
10.1101/2020.04.20.052159 — Posted: 2020-04-21 Discussion: Onsite
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
Walker, A., Fan, H., Keown, J. R., Margitich, V., Grimes, J. M., Fodor, E., te Velthuis, A. J.
10.1101/2020.04.21.053017 — Posted: 2020-04-21 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).